ArticleInternational journal of clinical oncology2024

The lymphocyte-to-monocyte ratio as a significant inflammatory marker associated with survival of patients with metastatic renal cell carcinoma treated using nivolumab plus ipilimumab therapy.

Kazuyuki Numakura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.